Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001394548-17-000010

Director acquired 2,525 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Einhorn Irving M. Director 2017-01-20 Grant or award +2,525 $1.98 $5,000 2,525 D
Loading xslF345X03/primary_doc.xml…